Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Indication Matters: Study Shows Trial Characteristics Of Approved Drugs Vary Widely Across Diseases

Jan 27 2014

• By Sarah Karlin-Smith

Related Content

IoM Drug Safety Report Recommends Sweeping Changes At CDER

Sep 25 2006

Orphan Products Mostly Approved With Regulatory Flexibility, NORD "Catalog" Finds

Oct 17 2011

Many Drug Approval Delays, Denials Could Be Prevented, FDA Study Shows

Jan 21 2014

FDA Puts “Safety First” For Post-Market Issues

Feb 27 2008

FDA Flexible With Accelerated Approval Evidence, Analysis Finds

Sep 02 2013

Additional Topics

United States Clinical Trials Regulation Drug Approval Standards Approvals BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window